October 23, 2009 – Modifying the risk of peripheral arterial disease (PAD) with healthy lifestyle changes remains vital to one's health, note researchers in a recent issue of the Journal of Vascular and Interventional Radiology.
October 23, 2009 – The first randomized intra-arrest cooling study has been selected for presentation as a late-breaking trial during the American Heart Association's (AHA) Scientific Sessions in November.
October 22, 2009 – FlowCardia Inc. yesterday began its U.S. launch of the over the wire (OTW) delivery platform for the CROSSER 14S and CROSSER 14P peripheral chronic total occlusions (CTOs) recanalization catheters.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 22, 2009 – MAQUET Cardiovascular LLC said today it received European CE mark for the company's MEGA 8 Fr. 50 cc intra-aortic balloon (IAB) catheter.
October 22, 2009 – A study in the Oct. 27 issue of the Journal of the American College of Cardiology reports early positive results of implanting the Melody transcatheter pulmonary valve through a minimally invasive procedure instead of standard open-heart surgery in patients with congenital heart disease and a dysfunctional or absent pulmonary valve.
October 21, 2009 – Cook Medical is introducing six new products in parallel to provide better treatment options to treat peripheral arterial disease (PAD), including new microwires, stents and angioplasty balloons that are integral to Cook’s advanced Leg Therapy Program.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 21, 2009 – W. L. Gore and Associates today announced the first human implants of the next generation Conformable GORE TAG Thoracic Endoprosthesis for the treatment of thoracic aortic aneurysms (TAAs).
October 21, 2009 – King Pharmaceuticals Inc. said today the U.S. Food and Drug Administration issued a complete response letter regarding the new drug application (NDA) for its cardiac pharmacologic stress agent CorVue (binodenoson), and the company is working on a response.
October 21, 2009 – Raydiance Corp., developer of the world’s first commercial-grade ultrafast laser, said today it made a major breakthrough in manufacturing a wide variety of bioabsorbable materials with precise, micron-resolution feature sizes and with no heat affected zones (HAZ).
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
October 21, 2009 – Carestream Health Inc. yesterday announced the availability of its new Web-based cardiology PACS that provides an efficient enterprise-wide image and information management solution for cardiology data. The CARESTREAM Cardiology PACS is now available in the United States, Canada, United Kingdom, Netherlands and Italy.
October 21, 2009 - GE Healthcare launched a new solution that puts clinical data and treatment practices in the hands of doctors and clinicians in real-time so that they can make informed decisions right at the point of care.
October 20, 2009 - Sen. Debbie Stabenow (D-Michigan), joined by representatives of the American Medical Association (AMA), American Association of Retired Persons (AARP) and the Military Officers Association of America at a Capitol Hill news conference, urged lawmakers to reverse $247 billion in projected Medicare reimbursement cuts to doctors.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
October 20, 2009 – ScottCare Corp. this week released the Chroma Holter monitor, which the company says is the industry’s first full-color Holter monitor that more effectively addresses the needs of both the patient and the clinician.
October 19, 2009 – iMobileHealth yesterday launched the iAorticValve Web site and iPhone application to allow doctors and patients to access and use critical aortic valve information and have it at their fingertips in a mobile form.
October 19, 2009 – Boehringer Ingelheim Pharmaceuticals Inc.